阿斯-211放射性药物;现状,趋势和未来
Mobina Rabiei1, Mahboobeh Asadi2, Hassan Yousefnia3
1Nuclear Engineering School, Islamic Azad University Shahrood Branch, Shahrud, Iran.
Current radiopharmaceuticals
|November 8, 2023
概括
由于阿尔法颗粒的排放,Astatine-211 (211At) 对向放射治疗具有前景,但其临床应用面临生产和可访问性挑战. 未来的开发旨在克服这些障碍,以便在癌症治疗中更广泛地使用.
科学领域:
- 核医学就是核医学.
- 放射性药物化学 放射性药物化学
- 在瘤学瘤学.
背景情况:
- 阿尔法发射器提供向的癌细胞破坏,减少了非向毒性.
- 阿斯-211 (211At) 对向放射治疗具有有利的衰变特性.
- 现有研究表明211At在临床前癌症模型中的有效性.
研究的目的:
- 审查Astatine-211 (211At) 的生产,放射性标记和临床应用.
- 讨论基于211At的放射性药物开发的挑战和未来趋势.
- 评估211At放射性药物临床试验的现状.
主要方法:
- 关于211At生产和无线电标记技术的文献综述.
- 发表的临床前和临床研究分析涉及211At.
- 对211At利用的后勤和成本因素的检查.
主要成果:
- 与其他放射性同位素相比,211At在临床前研究中显示出显著的治疗效果.
- 211的生产,分离和无线电标记目前存在相当大的障碍.
- 对于211At放射性药物存在有限的临床试验,通常是由于可访问性问题.
结论:
- 211At是针对性放射治疗的有前途的α发射剂,特别是在前列腺癌和骨微瘤.
- 克服生产和后勤障碍对于推进211At临床应用至关重要.
- 尽管目前存在局限性,但行业的兴趣表明,基于211At的放射性药品的未来增长.
关键词:
一个阿尔法发射器.一个statine-21111是什么在211At的生产.放射性同位素的放射性同位素无线电标记是指无线电标记.放射性药物. 放射性药物. 放射性药物. 放射性药物. 放射性药物. 放射性药物.更多相关视频
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020
10.0K
![Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F55537.jpg&w=3840&q=50)
11:03Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases
Published on: May 29, 2017
10.0K
相关概念视频
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
125
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
125
01:29Positron Emission Tomography
4.2K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.2K
01:13Radiological Investigation III: Pulmonary Angiogram and PET Scan
97
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
97